1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy : A Population-Based Cohort Study
Tryggvadottir, Helga LU ; Sandén, Emma LU ; Björner, Sofie LU ; Bressan, Alessandra ; Ygland Rödström, Maria ; Khazaei, Somayeh LU ; Edwards, Dean P. ; Nodin, Björn LU ; Jirström, Karin LU
and Isaksson, Karolin
LU
, et al.
(2021)
In Frontiers in Oncology
11.
- Contribution to journal › Article
- 2020
-
Mark
Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment
Sandén, Emma LU ; Khazaei, Somayeh LU ; Tryggvadottir, Helga LU ; Borgquist, Signe LU ; Isaksson, Karolin LU ; Jirström, Karin LU
and Jernström, Helena
LU
(2020)
In Virchows Archiv
477(2).
p.317-320
- Contribution to journal › Article
-
Mark
Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
Nilsson, Linn LU ; Sandén, Emma LU ; Khazaei, Somayeh LU ; Tryggvadottir, Helga LU ; Nodin, Björn LU ; Jirström, Karin LU
; Borgquist, Signe
LU
; Isaksson, Karolin
LU
and Jernström, Helena
LU
(2020)
In Frontiers in Oncology
10.
- Contribution to journal › Article